Quick Verdict
ARA-290
Risk
Half-life
~3 hours
Endoluten
Risk
Half-life
—
Side-by-Side Comparison
About ARA-290
Non-hematopoietic EPO analogue; activates innate repair receptor (IRR/EPOR/CD131 complex) without erythropoietic effects; promotes tissue repair and nerve healing
A modified erythropoietin peptide that activates tissue repair pathways without stimulating red blood cell production. Strong evidence for neuropathic pain and sarcoidosis.
Research Areas
About Endoluten
Pineal-targeted peptide complex that modulates melatonin synthesis pathways and circadian gene expression. May help restore age-related decline in pineal activity and improve circadian rhythm regulation.
A short peptide bioregulator derived from pineal gland tissue, developed by the Khavinson Institute. Studied for circadian rhythm restoration, melatonin pathway support, and longevity — addressing the age-related decline in pineal gland function.
Research Areas
Find Providers
Where to source these peptides
Providers offering
ARA-290
12 listed
Browse directory →
Providers offering
Endoluten
1 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More longevity Comparisons
Browse all peptides →Educational research tools — not medical advice.